CDXC Message Board Post 9184830 | ChromaDex Corporation
home / stock / cdxc / cdxc message board
Martel
(investorshub)
Posted on: Feb/25/2021 22:39:00
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162151574
Then I'm also sure you noticed the amended
News, Short Squeeze, Breakout and More Instantly...
-
ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy-aging research, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in the Lytham Partners Spring 2024 Investor ...
-
Judges award Niagen for its “high-quality, unparalleled” healthy aging research ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD + ) and healthy aging research, is proud to announce that its flagship ingredient, Niagen ...
-
Total net sales of $22.2 million, gross margin of 60.7%, a net loss of $0.5 million and a positive Adjusted EBITDA of $0.7 million for the three months ended March 31, 2024. Reiterated full year outlook including net sales growth of at least 16%. ChromaDex Corp. (NASDAQ:CDXC) today anno...